Heterologous Prime-boost of SARS-CoV-2 inactivated vaccine and mRNA BNT162b2 among Healthy Thai Adolescents

BACKGROUND: Heterologous prime-boost SARS-CoV-2 vaccination is a widely accepted strategy during the COVID-19 pandemic, which generated a superior immune response than homologous vaccination strategy. OBJECTIVE: To describe immunogenicity of heterologous prime-boost vaccination with inactivated vacc...

Descripción completa

Detalles Bibliográficos
Autores principales: Puthanakit, Thanyawee, Nantanee, Rapisa, Jaru-Ampornpan, Peera, Chantasrisawad, Napaporn, Sophonphan, Jiratchaya, Meepuksom, Thutsanun, Jupimai, Thidarat, Sodsai, Pimpayao, Anugulruengkitt, Suvaporn, Hirankarn, Nattiya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Regular paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422341/
https://www.ncbi.nlm.nih.gov/pubmed/36059600
http://dx.doi.org/10.1016/j.jvacx.2022.100211

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422341/
https://www.ncbi.nlm.nih.gov/pubmed/36059600
http://dx.doi.org/10.1016/j.jvacx.2022.100211

Ejemplares similares